Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder. [electronic resource]
Producer: 20200218Description: 76-83 p. digitalISSN:- 1473-5857
- Adult
- Akathisia, Drug-Induced -- drug therapy
- Antidepressive Agents
- Antipsychotic Agents -- adverse effects
- Combined Modality Therapy
- Depressive Disorder, Major -- drug therapy
- Dopamine Agonists -- adverse effects
- Female
- Headache
- Humans
- Male
- Middle Aged
- Piperazines -- adverse effects
- Suicide
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.